Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**UGT2A3P7** is a pseudogene in the human genome belonging to the UDP glucuronosyltransferase (UGT) gene family. It is annotated as "UDP glucuronosyltransferase 2 family, polypeptide A3 pseudogene 7". As a pseudogene, it does not encode a functional protein and does not exhibit enzymatic, transporter, receptor, or other canonical molecular target activity. There is no evidence in current scientific databases that UGT2A3P7 has any biological function, relevance as a drug target, disease association, or pharmacological significance[3][5]. **Context and Supporting Details:** - UGT2A3P7 is specifically identified as a **pseudogene** in authoritative genetic databases, meaning it is a non-functional copy or fragment of a related functional gene[3][5]. - Unlike the related gene UGT2A3, which encodes an active UDP-glucuronosyltransferase enzyme involved in drug metabolism and detoxification[9], UGT2A3P7 does not code for any protein and has no reported function or involvement in glucuronidation, disease pathways, or drug response. - No evidence is present that UGT2A3P7 interacts with drugs, serves as a biomarker, or is involved in disease mechanisms. - Sources describing UGT2A3P7, including commercial reagent databases and genomic information resources, list it as a **pseudogene** only, with no further biological or pharmacological role[3][5]. **Important note:** As a pseudogene, UGT2A3P7 is *not* a molecular target for drugs, is *not* considered a receptor, enzyme, transporter, or any related therapeutic target type, and it is possible that the entity was included based on a misinterpretation of nomenclature (i.e., confusing UGT2A3P7 with its functional paralog UGT2A3). Therefore, "is_incorrect" is set to true, as it is not a valid drug target or functional biological entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on UDP glucuronosyltransferase 2 family, polypeptide A3 pseudogene 7 (UGT2A3P7).